Related Experiment Videos
Effect of antenatal glucocorticoids on clinical closure of the ductus arteriosus
Insights
Antenatal glucocorticoids significantly reduced the incidence of patient ductus arteriosus (PDA) in preterm infants under 2,000 g. This finding highlights a potential protective effect of maternal steroid treatment on neonatal cardiovascular health.
Area of Science:
- Neonatal Medicine
- Perinatology
- Pediatric Cardiology
Background:
- Preterm infants, especially those with low birth weight (<2,000 g), are at high risk for developing a patient ductus arteriosus (PDA).
- A PDA is a persistent opening between the aorta and pulmonary artery, potentially leading to significant cardiopulmonary complications in neonates.
Purpose of the Study:
- To investigate the effect of antenatal glucocorticoid exposure on the incidence of clinically detectable patient ductus arteriosus (PDA) in preterm infants.
- To compare PDA rates in infants exposed versus unexposed to maternal antenatal glucocorticoids.
Main Methods:
- Retrospective comparison of two groups of preterm infants (<2,000 g birth weight).
- One group received antenatal glucocorticoids; the other did not.
- PDA diagnosis based on clinical signs: heart murmur, increased precordial activity, bounding peripheral pulses beyond day 3.
Main Results:
- A PDA was detected in 44% (14/32) of infants not exposed to antenatal glucocorticoids.
- Only 6.5% (1/15) of infants whose mothers received antenatal glucocorticoids showed evidence of PDA.
- Groups were similar regarding ruptured membranes, small-for-gestational-age status, and clinical management.
Conclusions:
- Antenatal glucocorticoid administration to mothers appears to significantly decrease the incidence of patient ductus arteriosus in preterm infants.
- This suggests a protective role for antenatal steroids in preventing this common neonatal complication.
Abstract:
The incidence of clinically detectable patient ductus arteriosus (PDA) in a group of preterm infants whose birth weights were less than 2,000 g was compared with that of a similar group of infants whose mothers received antenatal glucocorticoids. A PDA was diagnosed on the basis of a typical heart murmur, increased precordial activity, and bounding peripheral pulses beyond the third day of life. Whereas 14 (44%) of 32 infants who were not exposed to antenatal glucocorticoids showed evidence of a PDA, only one (6.5% of 15 infants whose mothers received antenatal glucocorticoids had similar findings. The incidence of ruptured membranes (greater than 72 hours), the number of infants who were small for gestational age, and clinical management of the infants in the two groups were similar.